Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000584531 | SCV000690621 | likely benign | Hereditary cancer-predisposing syndrome | 2016-12-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002065100 | SCV002385899 | likely benign | Familial adenomatous polyposis 2 | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000584531 | SCV004849141 | uncertain significance | Hereditary cancer-predisposing syndrome | 2015-06-09 | criteria provided, single submitter | clinical testing | The c.998-19C>T intronic alteration consists of a C to T substitution 19 nucleotides before coding exon 12 in the MUTYH gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV004543292 | SCV004760966 | likely benign | MUTYH-related disorder | 2019-12-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |